ELAB ELAB
Company Profile ↓Company Overview
ELAB (ELAB) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -65.5%.
- 5-Year Trend Long-term compounding — revenue CAGR -12.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -12.25% |
| 1 Year: | -65.54% |
Stock Price Performance
| 1 Year: | -99.42% |
| 6 Months: | -91.88% |
| 3 Months: | -55.46% |
| 1 Month: | -17.66% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)41.36 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -12.2% CAGR over 5 years.
- Trading 99.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 432.12M | 142.82K | 316.53K | 554.65K | 614.56K | 605.53K | 527.48K | - | - | 285.95K | 681.99K |
| Gross Profit | 237.69M | 98.39K | 208.35K | 366.14K | 445.65K | 439.25K | 393.90K | - | - | 78.03K | 230.47K |
| Operating Income | - | -846.39K | -1.05M | -785.55K | -1.68M | -1.41M | -625.62K | - | - | -2.20M | - |
| Net Income | -499.08M | -1.08M | -1.28M | -783.05K | -1.40M | -1.41M | -1.50M | -1.61M | -562.36K | -2.59M | -4.97M |
| Diluted EPS | -0.05 | -0.11 | -0.13 | -0.08 | -0.08 | -0.08 | -0.07 | - | - | - | - |
| R&D Expense | 89.33M | 83.74K | 133.65K | 86.37K | 2.78K | 34.82K | 4.10K | 32.43K | 66.67K | 15.00K | 47.06K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 766.28K | 1.71M | - | 590.08K |
| Gross Profit | 447.31K | 1.13M | - | 185.31K |
| Net Income | -1.80M | -4.30M | -6.25M | -7.75M |
| Diluted EPS | -0.19 | -0.40 | - | - |
| R&D Expense | 228.75K | 7.41K | 104.65K | 147.01K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.89M | 5.19M | 8.99M | 12.87M |
| Total Equity | 450.63K | 1.13M | 3.83M | 6.66M | 7.84M |
| Cash & Equivalents | - | - | 3.33M | 3.98M | - |
| Total Liabilities | - | 760.87K | 1.36M | 2.33M | 5.03M |
| Current Liabilities | - | 588.27K | 1.30M | 1.80M | 3.94M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -1.59M | -4.56M | -5.49M | -5.93M |
| Investing Cash Flow | -32.03K | -11.19K | -610.56K | -2.77M |
| Financing Cash Flow | 2.36M | 6.74M | 6.76M | 10.12M |
| Capital Expenditure | - | -11.19K | -9.16K | -442.25K |
| Free Cash Flow | - | -4.57M | -5.50M | -6.38M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 58.4% | 66.2% | - | 31.4% |
| Operating Margin % | - | - | - | - |
| Net Margin % | -234.9% | -251.2% | - | -1,313.0% |
| ROE % | -159.1% | -112.4% | -93.8% | -98.9% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ELAB
PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities Requirement
Company Reports 8,095,835 Shares of Common Stock Issued and Outstanding as of July 29, 2026, and Moves to Correct Third-Party Market Data That Understates Its Current Share Count and Market CapitalizationNEWPORT BEACH, Calif., July 29, 2026…
PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.
Two-year renewable long-term agreement establishes A&B Aerospace as a precision manufacturing supplier to PAD Group and its subsidiaries across aerospace and defense programs. Agreement enables A&B Aerospace to support purchase orders conne…
NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications
Definitive license agreement formalizes exclusive, worldwide, sublicensable rights to patented multi-domain drone payload technology for aerospace and defense applicationsAgreement follows the binding term sheet and sponsored research agree…
PMGC Holdings Advances EL-22 FACS Analysis to Support Manufacturing Comparability
The planned analytical study is designed to strengthen manufacturing characterization of EL-22 as development of the company’s engineered probiotic therapy continues. Key Investor TakeawaysPMGC Holdings (NASDAQ:ELAB), through subsidiary Nor…
PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace
Strategic consolidation of two precision manufacturing portfolio companies expected to streamline operations, shared resources, and strengthen the companies’ aerospace manufacturing platform NEWPORT BEACH, Calif., July 06, 2026 (GLOBE NEWSW…
GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.
VANCOUVER, British Columbia, May 18, 2026 (GLOBE NEWSWIRE) -- GB Capital Ltd. ("GB Capital"), a strategic finance, advisory and management firm, today announced that it served as co-advisor to PMGC Holdings Inc. (NASDAQ: ELAB) ("PMGC") on P…
ELAB — Frequently Asked Questions
What is the current share price of ELAB?
As of 2026-08-05 17:25 PDT, ELAB trades at $0.98 on NASDAQ/NYSE. Its 52-week range is $0.88 to $216.72.
What is the P/E ratio of ELAB?
ELAB trades at a trailing price-to-earnings (P/E) ratio of -2.45.
What is the return on equity (ROE) of ELAB?
ELAB has a return on equity (ROE) of -98.86%.
Is ELAB a good stock to buy?
This page provides a data-driven analysis of ELAB, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.